Analytic review of bimatoprost, latanoprost and travoprost in primary open angle glaucoma

By Holmstrom Stefan   Buchholz Patricia   Walt John   Wickstrøm Jannie   Aagren Mark  

Current Medical Research and Opinion, Vol. 21, Iss. 11, 2005-11 ,pp. : 1875-1883

Informa Healthcare

Access to resources Recommend Favorite

Brimonidine purite 0.1% versus brinzolamide 1% as adjunctive therapy to latanoprost in patients with glaucoma or ocular hypertension

By Day Douglas G.   Hollander David A.  

Current Medical Research and Opinion, Vol. 24, Iss. 5, 2008-05 ,pp. : 1435-1442

Informa Healthcare

Access to resources Recommend Favorite

An update on bimatoprost (Lumigan^®®) in glaucoma therapy

By Noecker Robert J   Earl Melissa L  

Therapy, Vol. 1, Iss. 1, 2004-09 ,pp. : 31-41

Future Medicine

Access to resources Recommend Favorite

Travoprost versus latanoprost combinations in glaucoma: economic evaluation based on visual field deficit progression

By Schmier Jordana K.   Halpern Michael T.   Covert David W.   Robin Alan L.  

Current Medical Research and Opinion, Vol. 22, Iss. 9, 2006-09 ,pp. : 1737-1743

Informa Healthcare

Access to resources Recommend Favorite

The cost-effectiveness of bimatoprost, latanoprost and timolol in treatment of primary open angle glaucoma in five European countries

By Holmstrom Stefan   Buchholz Patricia   Walt John   Wickstrøm Jannie   Aagren Mark  

Current Medical Research and Opinion, Vol. 22, Iss. 5, 2006-05 ,pp. : 897-905

Informa Healthcare

Access to resources Recommend Favorite